MedTrace Logo

Screening for Early Cervical Cancer Detection

NCT06550583 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-08-13

No results posted yet for this study

Summary

This study is to audit results and adherence to Cervical Screening program before and after the implementing awareness of the WHO guidelines of screening among the multidisciplinary healthcare workers and patients.

Conditions

Interventions

DIAGNOSTIC_TEST

Pap smear /Test

Patients will be placed in the lithotomy position, and a sterile bivalve speculum will be inserted into the vagina. • A sample will be taken from the ectocervix by rotating a wooden Ayre spatula 360°. The sample will be quickly smeared onto a labeled glass slide and fixed with 95% ethyl alcohol in a jar to be sent to the Department of Pathology for cytopathological examination

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mohamed M Soliman, physician · Assiut University

  • Hisham A Alsayed Abotaleb, professor · Assiut University

  • Hazem S Eldeen Mohammed, professor · Assiut University

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-08-30
Completion
2024-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06550583 on ClinicalTrials.gov